CURE’s gynecologic cancer page is an extensive resource of cancer information featuring the latest gynecologic cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on gynecologic cancer.
December 16th 2021
The vaccine, which protects patients from seven different strains related to HPV-related cancers, may be considered part of routine oncology care for survivors.
October 13th 2021
The FDA approved Keytruda for use with chemotherapy with or without bevacizumab, for the treatment of a subset of patients with cervical cancer.
October 6th 2021
Side effects from early-onset menopause from medical treatments may be mitigated with hormone replacement therapy.
September 20th 2021
Tivdak is a targeted therapy that showed promising results for patients with pretreated metastatic or recurrent cervical cancer.
August 5th 2021
Transvaginal ultrasonography may inaccurately measure uterine lining in Black women, highlighting the potential to assess its use on a case-by-case basis.
July 22nd 2021
The Food and Drug Administration approved Keytruda plus Lenvima for patients with advanced endometrial carcinoma whose disease had progressed after previous systemic therapy and are not candidates for surgery or radiation.
April 22nd 2021
Jemperli (dostarlimab) received accelerated approval from the Food and Drug Administration for the treatment of patients with recurrent or advanced endometrial cancer whose disease has progressed on, or following, prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic biomarker known as deficient mismatch repair.
March 17th 2021
As more is learned about the biology of endometrial cancer, new treatment possibilities emerge.
March 8th 2021
In honor of International Women’s Day, CURE® compiled some recent news and updates in women’s cancers that patients, survivors and caregivers may have missed.